VDR and cancer: In organ culture models, VDR agonists such as 25(OH)D3 and 1α,25(OH)2D3 reduce the incidence of DMBA induced pre-neoplastic lesions (Mehta et al., 1997; Peng et al., 2009) suggesting direct anti-cancer effects of these metabolites on mammary tissue.